Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

Inclusion Criteria: * Pre-menopausal patients between age of 20 and 50. * Patients with cervical intraepithelial neoplasia 3(CIN3). * Only infection with HPV type 16. * Patients with Capable of observation of all of lesions by Colposcopy biopsy. * Be informed of the nature of the study and will give written informed consent. * Be agree with contraception during study * White Blood Cell Count(WBC) over 4thous/ul, Hemoglobin above over 9.0g/dL Platelet over 150thous/uL and ANC(Absolute Neutrophil Count) over 1,500 /mm\^3 * Normal for EKG(Electrocardiography) * AST/ALT : 2.5 times less than normal range Exclusion Criteria: * Autoimmune Disease or Prohibited drug(Therapy) bring about immunosuppressive. * Patient that has medical history of hypersensitivity about Food containing Lactic acid bacteria or Lactic acid bacteria medication. * Patient with Acute illness(ex. Acute Appendicitis, Myocardial infarction, Hemorrhage, meningitis etc.) * Investigational product within three months before the start of the drug administration to patients treated with other test drug. * Patient with Chronic pancreatitis currently or Patients diagnosed with acute pancreatitis. * Organopathy Patient with Inflammatory intestine·bowel disease, gastrointestinal tumors, ulcers, bleeding, perforation etc. * Pregnant or lactating women * Patient with HBV or HCV infection (except for Asymptomatic) * Patient that Investigator judge * Deemed inappropriate for researchers to judge the patient